Aisling Capital Management LP Portfolio Holdings

Aisling Capital Management LP has filed its 13F form on February 12, 2025 for Q4 2024 where it was disclosed a total value porftolio of $273 Million distributed in 15 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bridge Bio Pharma, Inc. with a value of $167M, Verona Pharma PLC with a value of $51.8M, Syndax Pharmaceuticals Inc with a value of $13.6M, Monte Rosa Therapeutics, Inc. with a value of $10.2M, and Poseida Therapeutics, Inc. with a value of $10M.

Examining the 13F form we can see an increase of $29.9M in the current position value, from $243M to 273M.

Aisling Capital Management LP is based out at New York, NY

Below you can find more details about Aisling Capital Management LP portfolio as well as his latest detailed transactions.